Omada Health put to use part of their recent $57M funding round to acquire Physera, a musculoskeletal care company that uses telehealth and digital interventions to deliver ‘virtual physical therapy’ to those suffering from back, knee, and neck pain. How does the acquisition fit into Omada’s growth strategy? WTF Health’s Jessica DaMassa chats with both Omada Health’s CEO, Sean Duffy, and Dan Rubinstein, CEO of Physera, about the acquisition, the IPO buzz that continues to swirl around Omada, and whether or not the opportunity that COVID-19 has created for digital care will be lasting as we move forward.
Sean Duffy, CEO of Omada Health, proves why his company is one of those digital health startups everyone’s watching in the chronic condition management space. Never mind the buzz around their latest massive funding round or Livongo’s IPO, the real story here is Sean’s idea about building a “completely digital” care provider for folks with pre-diabetes, type II diabetes, hypertension, and mental health issues — or, at least that’s the goal for the next decade. What does a “full-stack view of supporting someone’s care look like? How do you get there? Tune in to find out about Omada’s proprietary tech-testing litmus test, “The Sean Duffy’s Mom Test,” and some good advice for other health tech startups about what it takes to win over clinicians with your tech.
Filmed at Health 2.0 in Santa Clara, California in September 2019.
Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew Holt. Get a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health.